Supplemental material
Open access
1,346
Views
9
CrossRef citations to date
0
Altmetric
Research Article
Novel FFA1 (GPR40) agonists containing spirocyclic periphery: polar azine periphery as a driver of potency
Mikhail KrasavinSaint Petersburg State University, Saint Petersburg, Russian Federation; Correspondence[email protected]
, Alexey LukinLomonosov Institute of Fine Chemical Technologies, Moscow Technological University, Moscow, Russian Federation;
, Daria BagnyukovaLomonosov Institute of Fine Chemical Technologies, Moscow Technological University, Moscow, Russian Federation;
, Nikolay ZhuriloLomonosov Institute of Fine Chemical Technologies, Moscow Technological University, Moscow, Russian Federation;
, Ihor ZahanichEnamine Ltd., Kyiv, Ukraine;
& Sergey ZozulyaEnamine Ltd., Kyiv, Ukraine; ;Taras Shevchenko National University, Kyiv, Ukraine
Pages 29-36
|
Received 22 Jul 2016, Accepted 20 Aug 2016, Published online: 26 Oct 2016
Related Research Data
Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.
Source:
American Chemical Society (ACS)
Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.
Source:
Springer Science and Business Media LLC
Spirocyclic amino alcohol building blocks prepared via a Prins-type cyclization in aqueous sulfuric acid
Source:
Elsevier BV
Novel agonists of free fatty acid receptor 1 (GPR40) based on 3-(1,3,4-thiadiazol-2-yl)propanoic acid scaffold
Source:
Taylor & Francis
Gram-scale synthesis of a novel core building block for the new GPR40 agonist design
Source:
Bentham Science Publishers Ltd.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.